Aldosterone impairs baroreflex sensitivity in healthy adults

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 1, 2007, Pages

  Monahan, Kevin D ^a   Leuenberger, Urs A ^a   Ray, Chester A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Blood pressure; Sympathetic; Vagus

Indexed keywords

ALDOSTERONE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE INNERVATION; NERVE CONDUCTION; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE;

ADAPTATION, PHYSIOLOGICAL; ADULT; ALDOSTERONE; BAROREFLEX; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE;

EID: 33846214767     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00622.2006     Document Type: Article

References (35)

1. Biglieri EG, McIlroy MB. Abnormalities of renal function and circulatory reflexes in primary aldosteronism. Circulation 33: 78-86, 1966.
2. Biglieri EG, McIlroy MB, Naimark A, Forsham PH. Altered autonomic nervous system and renal responses in primary aldosteronism (Abstract). J Clin Invest 41: 1345, 1962.
3. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med 154: 1490-1496, 1996.
4. Charkoudian N, Martin EA, Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ. Influence of increased central venous pressure on baroreflex control of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 287: H1658-H1662, 2004.
5. Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zeni P, Caruso B, Zardini P. Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 89: 403-407, 2002.
6. Ebert TJ, Cowley AW Jr. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am J Physiol Heart Circ Physiol 262: H1372-H1378, 1992.
7. Ebert TJ, Morgan BJ, Barney JA, Denahan T, Smith JJ. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 263: H798-H803, 1992.
8. Eckberg DL, Sleight P. Human Baroreflexes in Health and Disease. Oxford, UK: Clarendon, 1992.
9. Ferguson DW, Berg WJ, Roach PJ, Oren RM, Mark AL. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol 69: 523-531, 1992.
10. Fletcher J, Buch AN, Routledge HC, Chowdhary S, Coote JH, Townend JN. Acute aldosterone antagonism improves cardiac vagal control in humans. J Am Coll Cardiol 43: 1270-1275, 2004.
11. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001.
12. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92: 3206-3211, 1995.
13. Heindl S, Holzschneider J, Hinz A, Sayk F, Fehm HL, Dodt C. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans. J Neuroendocrinol 18: 115-121, 2006.
14. Jorde UP, Vittorio T, Katz SD, Colombo PC, Latif F, and Le Jemtel TH. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation 106: 1055-1057, 2002.
15. MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 35: 30-34, 1997.
16. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101: 862-868, 2000.
17. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 17: 1057-1062, 1991.
18. Monahan KD, Eskurza I, Seals DR. Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men. Am J Physiol Heart Circ Physiol 286: H2113-H2117, 2004.
19. Monahan KD, Ray CA. Cyclooxygenase inhibition and baroreflex sensitivity in humans. Am J Physiol Heart Circ Physiol 288: H737-H743, 2005.
20. Munakata M, Aihara A, Imai Y, Omata K, Abe K, Yoshinaga K. Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism. J Hypertens 13: 1648-1653, 1995.
21. Rudas L, Crossman AA, Morillo CA, Halliwill JR, Tahvanainen KU, Kuusela TA, Eckberg DL. Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. Am J Physiol Heart Circ Physiol 276: H1691-H1698, 1999.
22. Schmidt BM, Horisberger K, Feuring M, Schultz A, Wehling M. Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism. Exp Clin Endocrinol Diabetes 113: 252-256, 2005.
23. Schmidt BM, Montealegre A, Janson CP, Martin N, Stein-Kemmesies C, Scherhag A, Feuring M, Christ M, Wehling M. Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab 84: 3528-3533, 1999.
24. Slaton PE, Biglieri EG. Hypertension and hyperaldosteronism of renal and adrenal origin. Am J Med 38: 324-336, 1965.
25. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 24: 109-121, 1969.
26. Struthers AD. Aldosterone blockade in cardiovascular disease. Heart 90: 1229-1234, 2004.
27. Struthers AD. Aldosterone: cardiovascular assault. Am Heart J 144: S2-S7, 2002.
28. Sullebarger JT, Liang CS, Woolf PD, Willick AE, Richeson JF. Comparison of phenylephrine bolus and infusion methods in baroreflex measurements. J Appl Physiol 69: 962-967, 1990.
29. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82: 1730-1736, 1990.
30. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919-957, 1979.
31. Veglio F, Melchio R, Rabbia F, Molino P, Martini G, Chiandussi L. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism. Am J Hypertens 8: 479-486, 1995.
32. Veglio F, Molino P, Cat Genova G, Melchio R, Rabbia F, Grosso T, Martini G, Chiandussi L. Impaired baroreflex function and arterial compliance in primary aldosteronism. J Hum Hypertens 13: 29-36, 1999.
33. Wang W. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 24: 571-575, 1994.
34. Wang W, McClain JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 19: 270-277, 1992.
35. Yee KM, Struthers AD. Aldosterone blunts the baroreflex response in man. Clin Sci (Lond) 95: 687-692, 1998.